参考文献/References:
[1] 王德征,江国虹,张爽,等.1999—2015年天津市白血病死亡率变化趋势分析[J].中华预防医学杂志,2019,53(3):319-322.
[2] BLACKBURN L M,BENDER S,BROWN S.Acute leukemia:diagnosis and treatment[J].Semin Oncol Nurs,2019,35(6):150950.
[3] MUKHERJEE S,SEKERES M A.Novel therapies in acute myeloid leukemia[J].Semin Oncol Nurs,2019,35(6):150955.
[4] LIAO W,LIU X,YANG Q,et al.Deguelin inhibits HCV replication through suppressing cellular autophagy via down regulation of Beclin1 expression in human hepatoma cells[J].Antiviral Res,2020,174:104704.
[5] NGUYEN C T,ANN J,SAHU R,et al.Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90)[J].Bioorg Med Chem Lett,2020,30(17):127374.
[6] GAO F,YU X,LI M,et al.Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization[J].Cell Death Dis,2020,11(2):143.
[7] 赵明明,黄艳群,李莲,等.Wnt/β-catenin信号通路激活剂对过氧化氢诱导的星形胶质细胞凋亡的影响[J].临床和实验医学杂志,2018,17(9):25-29.
[8] CHOPRA M,BOHLANDER S K.The cell of origin and the leukemia stem cell in acute myeloid leukemia[J].Genes Chromosomes Cancer,2019,58(12):850-858.
[9] VOSBERG S,GREIF P A.Clonal evolution of acute myeloid leukemia from diagnosis to relapse[J].Genes Chromosomes Cancer,2019,58(12):839-849.
[10] NARAYANAN D,WEINBERG O K.How I investigate acute myeloid leukemia[J].Int J Lab Hematol,2020,42(1):3-15.
[11] LI H,TIAN X,WANG P,et al.MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2[J].Cell Mol Biol Lett,2019,4;24:66.
[12] CHEN L,JIANG K,CHEN H,et al.Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway[J].Cancer Manag Res,2018,11:95-105.
[13] LI W,YU X,MA X,et al.Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway[J].Cell Signal,2018,50:131-141.
[14] ZHANG X,ZHAO Z,YI S,et al.Deguelin induced differentiation of mutated NPM1 acute myeloid leukemia in vivo and in vitro[J].Anticancer Drugs,2017,28(7):723-738.
[15] KANG Y A,PIETRAS E M,PASSEGU E.Deregulated Notch and Wnt signaling activates early-stage myeloid regeneration pathways in leukemia[J].J Exp Med,2020,217(3):jem.20190787.
[16] YUAN Y,WANG Q,MA S L,et al.lncRNA PCAT-1 interacting with FZD6 contributes to the malignancy of acute myeloid leukemia cells through activating Wnt/β-catenin signaling pathway[J].Am J Transl Res,2019,11(11):7104-7114.
相似文献/References:
[1]张婧婧,张楠,王侠,等.急性髓系白血病四色流式细胞术免疫学分型特点分析[J].新乡医学院学报,2011,28(03):323.
[2]崔珊珊,李雅慧,赵晨瑾,等.二甲双胍对人急性髓系白血病KG1a细胞增殖和凋亡的影响及其机制[J].新乡医学院学报,2021,38(10):901.[doi:10.7683/xxyxyxb.2021.10.001]
CUI Shanshan,LI Yahui,ZHAO Chenjin,et al.Effect and mechanism of metformin on proliferation and apoptosis of human acute myeloid leukemia KG1a cells[J].Journal of Xinxiang Medical University,2021,38(12):901.[doi:10.7683/xxyxyxb.2021.10.001]
[3]张彦平,刘蒙蒙,展新荣.地西他滨联合小剂量高三尖杉酯碱和阿糖胞苷治疗老年急性髓系白血病疗效观察[J].新乡医学院学报,2020,37(11):1068.[doi:10.7683/xxyxyxb.2020.11.014]
ZHANG Yanping,LIU Mengmeng,ZHAN Xinrong.Effect of decitabine combined with low-dose homoharringtonine and cytarabine in the treatment of elderly patients with acute myeloid leukemia[J].Journal of Xinxiang Medical University,2020,37(12):1068.[doi:10.7683/xxyxyxb.2020.11.014]
[4]申清云,高 大.老年急性髓系白血病的治疗方法研究进展[J].新乡医学院学报,2019,36(1):096.[doi:10.7683/xxyxyxb.2019.01.022]
[5]张彦平,刘蒙蒙,展新荣.地西他滨联合三氧化二砷治疗老年急性髓系白血病的疗效及安全性[J].新乡医学院学报,2019,36(12):1163.[doi:10.7683/xxyxyxb.2019.12.015]
ZHANG Yan-ping,LIU Meng-meng,ZHAN Xin-rong.Evaluation of the efficacy and safety of decitabine combined with arsenic trioxide in the treatment of senile acute myeloid leukemia[J].Journal of Xinxiang Medical University,2019,36(12):1163.[doi:10.7683/xxyxyxb.2019.12.015]
[6]王继芳,魏秀丽.氟达拉滨联合阿糖胞苷治疗急性髓系白血病疗效观察[J].新乡医学院学报,2018,35(3):204.[doi:10.7683/xxyxyxb.2018.03.011]
WANG Ji-fang,WEI Xiu-li.Effect of fludarabine combined with cytarabine on acute myeloid leukemia[J].Journal of Xinxiang Medical University,2018,35(12):204.[doi:10.7683/xxyxyxb.2018.03.011]
[7]尹俊杰,梁 波,王继芳,等.阿柔比星为基础的联合化学治疗方案治疗成人初治急性髓系白血病疗效观察[J].新乡医学院学报,2017,34(1):072.[doi:10.7683/xxyxyxb.2017.01.021]
YIN Jun-jie,LIANG Bo,WANG Ji-fang,et al.Efficacy of aclarubicin-based chemotherapy induction regimens for adult de-novo acute myeloid leukemia[J].Journal of Xinxiang Medical University,2017,34(12):072.[doi:10.7683/xxyxyxb.2017.01.021]
[8]孟君霞,武永强,唐 广,等.CD7抗原表达与急性髓系白血病临床特征、细胞遗传学特点及预后的关系[J].新乡医学院学报,2016,33(6):508.[doi:10.7683/xxyxyxb.2016.06.017]
MENG Jun-xia,WU Yong-qiang,TANG Guang,et al.Relationship between CD7 antigen expression and clinical features,cytogenetic features,prognosis of acute myeloid leukemia[J].Journal of Xinxiang Medical University,2016,33(12):508.[doi:10.7683/xxyxyxb.2016.06.017]
[9]张晓冬,林晓媛.急性髓系白血病患者外周血调节性T细胞、辅助性T细胞17及其相关细胞因子的表达及意义[J].新乡医学院学报,2023,40(4):339.[doi:10.7683/xxyxyxb.2023.04.008]
ZHANG Xiaodong,LIN Xiaoyuan.Expression and significance of regulatory T cells,helper T cell 17 cells and their related cytokines in peripheral blood of patients with acute myeloid leukemia[J].Journal of Xinxiang Medical University,2023,40(12):339.[doi:10.7683/xxyxyxb.2023.04.008]
[10]纪婷婷,陶善东,丁邦和,等.非M3型急性髓系白血病患者骨髓原始细胞酪氨酸蛋白激酶CD117的表达及意义[J].新乡医学院学报,2024,(4):353.[doi:10.7683/xxyxyxb.2024.04.010]
JI Tingting,TAO Shandong,DING Banghe,et al.Expression of tyrosine protein kinase CD117 in patients with non-M3 acute myeloid leukemia and its significance[J].Journal of Xinxiang Medical University,2024,(12):353.[doi:10.7683/xxyxyxb.2024.04.010]